1. Home
  2. RUMBW vs NAMSW Comparison

RUMBW vs NAMSW Comparison

Compare RUMBW & NAMSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RUMBW
  • NAMSW
  • Stock Information
  • Founded
  • RUMBW N/A
  • NAMSW N/A
  • Country
  • RUMBW United States
  • NAMSW Netherlands
  • Employees
  • RUMBW 158
  • NAMSW 29
  • Industry
  • RUMBW Computer Software: Prepackaged Software
  • NAMSW Biotechnology: Pharmaceutical Preparations
  • Sector
  • RUMBW Technology
  • NAMSW Health Care
  • Exchange
  • RUMBW Nasdaq
  • NAMSW Nasdaq
  • Market Cap
  • RUMBW N/A
  • NAMSW N/A
  • IPO Year
  • RUMBW 2021
  • NAMSW N/A
  • Fundamental
  • Price
  • RUMBW $1.38
  • NAMSW $9.00
  • Analyst Decision
  • RUMBW
  • NAMSW
  • Analyst Count
  • RUMBW 0
  • NAMSW 0
  • Target Price
  • RUMBW N/A
  • NAMSW N/A
  • AVG Volume (30 Days)
  • RUMBW N/A
  • NAMSW N/A
  • Earning Date
  • RUMBW N/A
  • NAMSW N/A
  • Dividend Yield
  • RUMBW N/A
  • NAMSW N/A
  • EPS Growth
  • RUMBW N/A
  • NAMSW N/A
  • EPS
  • RUMBW N/A
  • NAMSW N/A
  • Revenue
  • RUMBW N/A
  • NAMSW N/A
  • Revenue This Year
  • RUMBW N/A
  • NAMSW N/A
  • Revenue Next Year
  • RUMBW N/A
  • NAMSW N/A
  • P/E Ratio
  • RUMBW N/A
  • NAMSW N/A
  • Revenue Growth
  • RUMBW N/A
  • NAMSW N/A
  • 52 Week Low
  • RUMBW N/A
  • NAMSW N/A
  • 52 Week High
  • RUMBW N/A
  • NAMSW N/A
  • Technical
  • Relative Strength Index (RSI)
  • RUMBW N/A
  • NAMSW 47.49
  • Support Level
  • RUMBW N/A
  • NAMSW $9.40
  • Resistance Level
  • RUMBW N/A
  • NAMSW $10.14
  • Average True Range (ATR)
  • RUMBW 0.00
  • NAMSW 0.44
  • MACD
  • RUMBW 0.00
  • NAMSW -0.12
  • Stochastic Oscillator
  • RUMBW 0.00
  • NAMSW 24.31

About RUMBW Rumble Inc. Warrant

Rumble Inc is a free-to-use video-sharing platform where users can watch, share, like, comment, and upload their own videos. Users can subscribe to channels to stay in touch with recent creator content and access video-on-demand uploaded, and live content streamed, by creators. Geographically, it generates a majority of its revenue from the United States.

About NAMSW NewAmsterdam Pharma Company N.V. Warrant

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Share on Social Networks: